Key Insights

Highlights

Success Rate

81% trial completion

Published Results

26 trials with published results (13%)

Research Maturity

113 completed trials (57% of total)

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 62/100

Termination Rate

13.6%

27 terminated out of 198 trials

Success Rate

80.7%

-5.8% vs benchmark

Late-Stage Pipeline

14%

27 trials in Phase 3/4

Results Transparency

23%

26 of 113 completed with results

Key Signals

26 with results81% success27 terminated

Data Visualizations

Phase Distribution

127Total
Not Applicable (35)
Early P 1 (2)
P 1 (15)
P 2 (48)
P 3 (15)
P 4 (12)

Trial Status

Completed113
Unknown42
Terminated27
Withdrawn7
Recruiting5
Suspended2

Trial Success Rate

80.7%

Benchmark: 86.5%

Based on 113 completed trials

Clinical Trials (198)

Showing 20 of 20 trials
NCT04367857Recruiting

ARMOR Study: COVID-19 Seroprevalence Among Healthcare Workers

NCT04369456Not ApplicableCompleted

Blood Biomarkers as Predictors of COVID-19 Disease Progression in Recently Infected Kidney Transplant Patients

NCT04333654Phase 1TerminatedPrimary

Hydroxychloroquine in Outpatient Adults With COVID-19

NCT04366934CompletedPrimary

Study of the Pathogenesis of Olfactory Disorders in COVID-19

NCT04427280Completed

Cancer: Rapid Diagnostics and Immune Assessment for SARS-CoV-2 (COVID-19)

NCT04885504RecruitingPrimary

Post COVID-19 Biorepository

NCT04335084Phase 2Completed

A Study of Hydroxychloroquine, Vitamin C, Vitamin D, and Zinc for the Prevention of COVID-19 Infection

NCT05593770Phase 2Terminated

International Sites: Novel Experimental COVID-19 Therapies Affecting Host Response

NCT04408170CompletedPrimary

Facilitating AcceLerated Clinical Validation Of Novel Diagnostics for COVID-19 (FALCON-C19)

NCT04527432Not ApplicableCompletedPrimary

COVID-19 Health Professional Impact Study

NCT04478071Phase 2Completed

Vadadustat for the Prevention and Treatment of Acute Respiratory Distress Syndrome (ARDS) in Hospitalized Patients With Coronavirus Disease 2019 (COVID-19)

NCT06864182Phase 1Completed

Relative Bioavailability Study of CX2101A for the Treatment of COVID-19

NCT04349371Phase 2Terminated

Saved From COVID-19 - Chloroquine (CQ) Prophylaxis for Health Care Workers at Risk for COVID

NCT04510025RecruitingPrimary

Capturing MultiORgan Effects of COVID-19

NCT04924660Phase 2Completed

Novel Experimental COVID-19 Therapies Affecting Host Response

NCT04348370Phase 4Completed

BCG Vaccine for Health Care Workers as Defense Against COVID 19

NCT04619368Completed

Post-intensive Care Follow-up of Patients Hospitalized for an Acute Respiratory Distress Syndrome Caused by COVID-19

NCT04482686Phase 1Completed

Trial of Combination Therapy to Treat COVID-19 Infection

NCT04765371Phase 3CompletedPrimary

Comparison Between Prednisolone and Dexamethasone on Mortality in Patients on Oxygen Therapy, with CoViD-19

NCT05178173Not ApplicableCompleted

Efficacy of Oral Rinses for Inactivation of COVID-19 (MOR2)

Scroll to load more

Research Network

Activity Timeline